Skip to main content
PLOS One logoLink to PLOS One
. 2023 Feb 8;18(2):e0279169. doi: 10.1371/journal.pone.0279169

Effects of gene–lifestyle interactions on obesity based on a multi-locus risk score: A cross-sectional analysis

Sho Nakamura 1,2,*, Xuemin Fang 1, Yoshinobu Saito 2,3,4, Hiroto Narimatsu 1,2,3,5, Azusa Ota 6, Hiroaki Ikezaki 6,7, Chisato Shimanoe 8, Keitaro Tanaka 9, Yoko Kubo 10, Mineko Tsukamoto 10, Takashi Tamura 10, Asahi Hishida 10, Isao Oze 11, Yuriko N Koyanagi 12, Yohko Nakamura 13, Miho Kusakabe 13, Toshiro Takezaki 14, Daisaku Nishimoto 15, Sadao Suzuki 16, Takahiro Otani 16, Nagato Kuriyama 17,18, Daisuke Matsui 17, Kiyonori Kuriki 19, Aya Kadota 20, Yasuyuki Nakamura 20,21, Kokichi Arisawa 22, Sakurako Katsuura-Kamano 22, Masahiro Nakatochi 23, Yukihide Momozawa 24, Michiaki Kubo 24, Kenji Takeuchi 10,25, Kenji Wakai 10
Editor: Tomoyoshi Komiyama26
PMCID: PMC9907830  PMID: 36753494

Abstract

Background

The relationship between lifestyle and obesity is a major focus of research. Personalized nutrition, which utilizes evidence from nutrigenomics, such as gene–environment interactions, has been attracting attention in recent years. However, evidence for gene–environment interactions that can inform treatment strategies is lacking, despite some reported interactions involving dietary intake or physical activity. Utilizing gene–lifestyle interactions in practice could aid in optimizing interventions according to genetic risk.

Methods

This study aimed to elucidate the effects of gene–lifestyle interactions on body mass index (BMI). Cross-sectional data from the Japan Multi-Institutional Collaborative Cohort Study were used. Interactions between a multi-locus genetic risk score (GRS), calculated from 76 ancestry-specific single nucleotide polymorphisms, and nutritional intake or physical activity were assessed using a linear mixed-effect model.

Results

The mean (standard deviation) BMI and GRS for all participants (n = 12,918) were 22.9 (3.0) kg/m2 and -0.07 (0.16), respectively. The correlation between GRS and BMI was r(12,916) = 0.13 (95% confidence interval [CI] 0.11–0.15, P < 0.001). An interaction between GRS and saturated fatty acid intake was observed (β = -0.11, 95% CI -0.21 to -0.02). An interaction between GRS and n-3 polyunsaturated fatty acids was also observed in the females with normal-weight subgroup (β = -0.12, 95% CI -0.22 to -0.03).

Conclusion

Our results provide evidence of an interaction effect between GRS and nutritional intake and physical activity. This gene–lifestyle interaction provides a basis for developing prevention or treatment interventions for obesity according to individual genetic predisposition.

Introduction

Obesity is one of the leading causes of death by increasing the risk of non-communicable diseases, such as cardiovascular diseases, type-2 diabetes, musculoskeletal disorders, and cancers [1]. The prevalence of obesity is increasing worldwide, necessitating the development of more effective prevention and treatment strategies. Both environmental and genetic factors are responsible for obesity. Environmental factors include diet, exercise, and the obesogenic environment, including socioeconomic, ethnic, cultural, and geographical factors; notably, some of these factors are beyond an individual’s control [2, 3]. In addition, an obesogenic environment could affect lifestyle factors, such as diet and exercise.

The independent effects of these factors on body mass index (BMI) are limited. Rather, combinations and interactions between environmental and genetic factors have a relatively large effect on BMI. Gene–environment interactions contributing to BMI have therefore attracted substantial attention [46]; the effect of environmental factors on BMI is modified by genetic factors. Recent research aims to identify gene–environment interactions that can serve as a basis for the prevention or treatment of obesity. However, the results of these studies have been contradictory and inconsistent, despite some evidence indicating that the effects of dietary intake, physical activity, or socioeconomic status on BMI differ according to genetic risk [711]. The existence of gene–environment interactions indicates the importance of utilizing gene–lifestyle interactions in primary preventive intervention to select optimal intervention according to genetic risk. For example, personalized nutrition based on nutrigenomic evidence gives specific dietary advice to each individual based on one’s genetic information, rather than a general recommendation about diet [12].

In this study, we focused on the genetic risk score (GRS) calculated from multiple single nucleotide polymorphisms (SNPs) or loci (multi-locus GRS), diet, and physical activity to analyze gene–lifestyle interactions. Data are limited regarding the marginal effects of interactions when including nutrients, such as carbohydrates, fat, protein, dietary fiber, vitamins, and physical activity in a single statistical model. Such a gene–lifestyle interaction would help advance the utilization of genetic risk in managing obesity since diet and physical activity are the two major components of lifestyle interventions for obesity. This study aimed to explore the interaction between genetic risk and lifestyle factors, such as nutritional intake and physical activity, on BMI using cross-sectional data from the Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study).

Materials and methods

Study population

Data were obtained from the J-MICC Study (ver. 20190720), a genomic cohort study launched in 2005. Details of the J-MICC study are described elsewhere [13, 14]. In brief, participants were residents of Japan who participated in health checkups held by local governments, volunteers, or patients recruited at their first visit to the cancer hospital, aged 35 to 69 years. Information on lifestyle and medical conditions were collected by a self-administered questionnaire, and various parameters, such as anthropometric traits and laboratory data from blood samples, including genomic information, were obtained in the baseline survey. Participants were recruited from 12 different areas throughout Japan (Aichi, Chiba, Fukuoka, Kagoshima, Kyoto, Kyushu-KOPS, Okazaki, Sakuragaoka, Saga, Shizuoka-Daiko, Takashima, and Tokushima) between 2004 and 2013. Written informed consent was obtained from all participants. The J-MICC Study was approved by the Ethics Committees of Nagoya University Graduate School of Medicine and the other institutions participating in the J-MICC study. This analysis was also approved by the ethics committee of the Kanagawa Cancer Center.

Genotyping, quality control, and genotype imputation

DNA was extracted from the buffy coat using a BioRobot M48 Workstation (QIAGEN Group, Tokyo, Japan). SNP genotyping was performed by the RIKEN Center for Integrative Medical Sciences using the Illumina OmniExpressExome Array (Illumina, San Diego, CA, USA). Inconsistencies in sex information between the questionnaire and genotype-based estimates were excluded (n = 26). The identity-by-descent method implemented in PLINK 1.9 found 388 closely related pairs (pi-hat > 0.1875), and one sample in each pair was excluded [15, 16]. Subjects whose ancestries were estimated to be outside of the Japanese population detected by a principal component analysis with a 1000 Genomes reference panel (phase 3) were excluded (n = 34) [1719]. SNPs with a genotype call rate of <0.98 and/or a Hardy–Weinberg equilibrium exact test p-value of <1 × 10−6, a low minor allele frequency (MAF) of <0.01, or an allele frequency difference > 20% between the scaffold and 1000 genomes phase 3 EAS (East Asian) samples were excluded. Quality control filtering resulted in 14,086 individuals and 570,162 SNPs [20]. Genotype imputation was performed using SHAPEIT version 2 and Minimac3 based on the 1000 Genomes Project (phase 3) as a cosmopolitan reference panel [21, 22].

Genetic risk score

SNPs used to calculate the GRS were selected from a genome-wide association study (GWAS) of the Japanese population reported by Akiyama et al. [23]. Details including the MAF and r2 of the selected 76 SNPs are shown in S1 Table. SNPs on chromosome X and SNPs identified by a sex-stratified analysis were excluded. The GRS was calculated from the β coefficients of these 76 SNPs using a previously reported weighting method [7, 8, 23]. In brief, GRS was calculated by summing the allelic dosage (0 to 2) for each SNP, which was weighted by the β coefficient reported in GWAS [2]. GRS was constructed with a theoretical range of -2.256 (possessing no predisposition allele) to 2.334 (possessing 152 predisposition alleles), where higher scores indicate a higher genetic predisposition to obesity. The calculated GRS was categorized into lower and upper groups according to the score in order to make the number of participants approximately equal in each group.

Phenotypes

Weight and height were measured at baseline and were used to calculate BMI (kg/m2). Missing values were complemented by BMI calculated using the self-reported height and weight (questionnaire). Daily nutritional intake and physical activity were assessed using the J-MICC Study questionnaire at baseline. The questionnaires were reviewed by trained staff for their credibility and consistency. Daily nutritional intake was assessed using a validated food frequency questionnaire (S1 Fig) [2426]. Nutritional intake was adjusted by total energy intake using the residual method. Daily physical activity was calculated, based on a previously reported method, in terms of metabolic equivalents-hours per day (METs-h/day) [27]. In brief, daily life activity and leisure-time activity were estimated based on the International Physical Activity Questionnaire [28]. The intensity of activity was categorized into five levels: walking, 3.0; and heavy physical work or exercise, 4.5 METs in daily life activities and 3.4, 7.0, and 10.0 METs for leisure-time activities. The intensity was multiplied by the length and frequency of each activity to obtain METs-h/day. We did not include standing time (2.0 METs) as we intended to assess moderate-to-vigorous physical activity (> 3 METs) in our analysis. Sitting time (h/day) was obtained from the questionnaire. Information for all parameters was available for 13,913 participants.

Statistical analysis

Statistical analyses were performed using R version 3.6.3 [29]. Pearson’s product-moment correlation between GRS and BMI was calculated, and a simple linear regression analysis was performed. A linear mixed-effects model (LMM) was constructed and fit by maximum likelihood using lme4 version 1.1-23 [30]. The effective degrees of freedom were approximated using the Welch-Satterthwaite method implemented in lmerTest version 3.1-2 [31]. The dependent variable was BMI with a recruited site-specific random intercept, and the fixed effects were GRS (lower and upper halves were coded 0 and 1, respectively), age, sex, BMI measurement method (estimates based on examined or self-reported were coded 0 and 1, respectively), 21 lifestyle factors, interaction terms between age and sex and between GRS and age, sex, and lifestyle factors. The interaction terms were assessed for their effects on BMI. The 21 lifestyle factors included daily nutritional intake (energy, protein, saturated fatty acids, monounsaturated fatty acids, n-3 polyunsaturated fatty acids, n-6 polyunsaturated fatty acids, carbohydrates, soluble dietary fiber, insoluble dietary fiber, retinol, vitamin D, vitamin E, vitamin B1, vitamin B2, folate, vitamin C, iron, and calcium), alcohol intake, MVPA, and sitting time. Continuous variables other than BMI and GRS were standardized based on z-score. Additionally, 995/13,913 (7.2%) participants were excluded owing to influential data points according to the residual, leverage, and Cook’s distance. Variable selection was performed by backward elimination with an alpha level of 0.05, partly using the step function in lmerTest [31]. Visual inspection of residual plots did not reveal any obvious deviations from homoscedasticity or normality. We performed a sensitivity analysis excluding the 1,082 participants recruited at the Cancer Center (Aichi 1, S2 Table). A subgroup analysis was also performed according to BMI (normal weight [>18.5 kg/m2, <25 kg/m2] or obesity [≥25 kg/m2]) and sex; subgroups 1–4 corresponded to males with normal weight, females with normal weight, males with obesity, and females with obesity, respectively. As sex was used as stratifying factor, it was dismissed in the subgroup analysis. Monounsaturated fatty acids and vitamin E in subgroup 2 were excluded from the model owing to multicollinearity. Variance inflation factors (VIF) were checked for multicollinearity using the vif function in car version 3.0-3 [32], and the highest VIF among all variables in 5 models was 3.4, indicating no substantial influence of multicollinearity on model results. The gene–lifestyle interaction was further explored using a different approach: candidate lifestyle factors were explored in the subgroup analysis according to GRS, followed by interaction analysis factor by factor (candidate approach). The detail of the candidate approach is described in detail in the S1 Appendix.

Results

Characteristics of the participants

Demographic, lifestyle, and genetic factors for study participants are shown in Table 1, including characteristics according to GRS subgroups used to generate covariance matrixes in the LMM. Participants were recruited from 12 sites, ranging from 466/12,918 participants (3.6%) at the smallest site to 1,888/12,918 participants (14.6%) (S2 Table). The mean (standard deviation) BMI for all participants was 22.9 (3.0) kg/m2, for male was 23.6 (2.8) kg/m2, and for female was 22.2 (3.0) kg/m2. In subgroups, there were 9,173 participants of normal weight (male/female 3,952/5,221) and 2,945 participants with obesity (male/female, 1,683/1,262) (S3 Table). There were no statistical differences in age, sex distribution, BMI, or the captured environmental variables between the two subgroups of the GRS (Table 1). The correlation between GRS and BMI was rho(12,916) = 0.13 (95% confidence interval [CI] 0.11–0.15, p < 0.001), and the increase in BMI for every unit increase in the GRS was 2.45 (95% CI 2.13–2.77, p < 0.001).

Table 1. Characteristics of the study participants.

Characteristics Subgroups, according to GRS
All participants Lower half Upper half
n = 12,918 n = 6,461 n = 6,457
Age (years) 54.7 ± 9.3 54.8 ± 9.3 54.6 ± 9.3
Sex (F, %) 7126 ± 55.2 3545 ± 54.9 3581 ± 55.5
BMI (kg/m 2 ) 22.9 ± 3.0 22.6 ± 2.9 23.2 ± 3.1
Measurement method (self-report, %) 2549 ± 19.7 1279 ± 19.8 1270 ± 19.7
Daily nutritional intakes
Energy (kcal) 1685.1 ± 336.2 1686.6 ± 335.4 1683.6 ± 337.1
Protein (g) 52.7 ± 7.0 52.6 ± 6.9 52.8 ± 7.1
Saturated fatty acids (g) 11.2 ± 2.5 11.1 ± 2.5 11.2 ± 2.4
Monounsaturated fatty acids (g) 16.0 ± 3.5 16.0 ± 3.4 16.1 ± 3.6
n-3 polyunsaturated fatty acids (g) 2.2 ± 0.5 2.2 ± 0.5 2.2 ± 0.5
n-6 polyunsaturated fatty acids (g) 10.9 ± 2.7 10.8 ± 2.7 10.9 ± 2.8
Carbohydrate (g) 240.6 ± 23.4 241.0 ± 23.4 240.2 ± 23.3
Total dietary fiber (g) 10.5 ± 2.8 10.5 ± 2.8 10.5 ± 2.8
Soluble dietary fiber (g) 1.9 ± 0.6 1.9 ± 0.6 1.9 ± 0.6
Insoluble dietary fiber (g) 7.6 ± 2.0 7.6 ± 2.0 7.6 ± 2.0
Retinol (mcg) 923.7 ± 360.6 919.7 ± 360.4 927.6 ± 360.9
Vitamin D (mcg) 7.1 ± 2.9 7.1 ± 2.9 7.1 ± 2.9
Vitamin E (mg) 8.0 ± 1.8 8.0 ± 1.8 8.0 ± 1.8
Vitamin B1 (mg) 0.6 ± 0.1 0.6 ± 0.1 0.6 ± 0.1
Vitamin B2 (mg) 1.1 ± 0.2 1.1 ± 0.2 1.1 ± 0.2
Folate (mcg) 326.0 ± 94.6 325.2 ± 93.7 326.7 ± 95.6
Vitamin C (mg) 94.3 ± 33.8 94.2 ± 33.5 94.5 ± 34.0
Calcium (mg) 505.1 ± 139.2 504.0 ± 140.2 506.3 ± 138.1
Iron (mg) 6.9 ± 1.7 6.9 ± 1.7 6.9 ± 1.7
Ethanol (g) 13.4 ± 22.5 13.2 ± 22.2 13.5 ± 22.8
Physical activity (METs-h/day) 13.7 ± 12.5 13.7 ± 12.4 13.6 ± 12.6
Sitting time (hours/day) 4.9 ± 3.7 4.9 ± 3.7 4.9 ± 3.7
GRS -0.07 ± 0.16 -0.20 ± 0.09 0.06 ± 0.10

Data are presented as means ± standard deviation, unless otherwise specified. GRS, genetic risk score; g, grams; mcg, micrograms; METs-h/day, metabolic equivalents-hours per day.

Gene–lifestyle interaction analysis

The results of the gene–lifestyle interaction analysis are summarized in Table 2. The final LMM included 15 predictors of relevance selected via stepwise regression with backward selection: GRS, age, sex, 8 nutritional factors, sitting time, and interaction terms for age × sex, GRS × age, and GRS × saturated fatty acids as fixed effects. BMI was approximated using the following equation:

Yij=23.3+j=111(θj+γj×sitej)+(0.63×GRSij)+k=111(βk×Xkij)+(0.56×[ageij*sexij])+(0.10×[GRSij*ageij])+(0.11×[GRSij*saturatedfattyacidsij])+ϵij,

where Yij = BMI (kg/m2), θj is the random intercept for the jth site dummy variable, γj is the coefficient for the jth site dummy variable, βk = coefficient for fixed effect k, Xkij = value of the fixed effect k for participant I at site j, ϵij = residual for participant I in recruited site j; and fixed effect k is either age, sex, protein, saturated fatty acids, n-3 polyunsaturated fatty acids, carbohydrate, soluble dietary fiber, retinol, vitamin D, vitamin B1 or sitting time. There were differences in BMI between the recruited sites with a variance of 0.39 kg/m2. The only interaction term with GRS and lifestyle factor that remained after the variable selection procedure was saturated fatty acids intake (Table 2). The interaction between GRS and saturated fatty acid intake (P = 0.021) is described in Fig 1. A negative association between saturated fatty acid intake and GRS was exaggerated in participants with a high GRS subgroup (upper half). The differences in BMI associated with 10 grams (4.0 standardized units) of saturated fatty acids per day were 0.27 kg/m2 and 0.74 kg/m2 in the low and high GRS subgroups, respectively. A comparable result was obtained from the sensitivity analysis (S4 Table).

Table 2. Effects of gene–lifestyle interactions on BMI.

Parameters
Random effects Variance Standard deviation
Recruited sites (intercept) 0.39 0.62
Residual 7.81 2.78
Fixed effects Coefficient estimate 95% confidence interval p-value
Intercept 23.34 22.98, 23.70 < 0.001
GRS (high GRS subgroup) 0.63 0.54, 0.73 < 0.001
Age 0.02 -0.08, 0.11 0.738
Sex (female) -1.35 -1.46, -1.24 < 0.001
Protein 0.20 0.10, 0.30 < 0.001
Saturated fatty acids -0.07 -0.16, 0.02 0.151
n-3 polyunsaturated fatty acids 0.21 0.14, 0.29 < 0.001
Carbohydrate 0.08 0.02, 0.14 0.008
Soluble dietary fiber -0.29 -0.35, -0.22 < 0.001
Retinol 0.09 0.03, 0.14 0.003
Vitamin D -0.19 -0.27, -0.10 < 0.001
Vitamin B1 0.07 0.01, 0.13 0.033
Sitting time 0.08 0.02, 0.15 0.012
Age * sex 0.56 0.46, 0.66 < 0.001
Genetic risk score * age -0.10 -0.20, -0.002 0.045
Genetic risk score * saturated fatty acids -0.11 -0.21, -0.02 0.021

Continuous variables other than BMI and GRS were standardized based on z-score. Variables selected by the backward reduction from the following fixed effects are shown: GRS (low and high GRS subgroups coded as 0 and 1), age, sex, BMI measurement method (calculated from examined or self-reported height and weight coded as 0 and 1), energy, protein, saturated fatty acids, monounsaturated fatty acids, n-3 polyunsaturated fatty acids, n-6 polyunsaturated fatty acids, carbohydrate, soluble dietary fiber, insoluble dietary fiber, retinol, vitamin D, vitamin E, vitamin B1, vitamin B2, folate, vitamin C, iron, and calcium, alcohol intake, moderate-to-vigorous physical activity, sitting time, interaction terms between age and sex, and GRS and age, sex, and each lifestyle factor. GRS, genetic risk score.

Fig 1. Graphical representation of the interaction between GRS and saturated fatty acid intake.

Fig 1

Red and blue lines indicate regression lines for individuals with GRS values in the lower half (GRS = 0) and upper half (GRS = 1). The shading around each regression line shows the 95% confidence interval. One unit of standardized saturated fatty acids intake (x-axis) corresponds to 2.5 g/day. The association between BMI and saturated fatty acid intake is greater in the group with a high GRS. GRS, genetic risk score.

Subgroup analysis according to BMI and sex

The results of a subgroup analysis are shown in Table 3, and the results of the interaction analysis are graphically presented in Fig 2. Among the lifestyle factors, gene–lifestyle interactions were observed for n-3 polyunsaturated fatty acids, vitamin B1, and sitting time. These interactions were prevalent only in subgroups of female participants. Notably, the association between lifestyle factors and GRS was exaggerated in the high GRS subgroups compared with the low GRS subgroup. Association between sitting time and BMI was only observed for the high GRS subgroup in females with obesity (subgroup 2). Variances of BMI between the recruited sites were largest in this subgroup. No gene-lifestyle interaction was observed for subgroup 1, while the association between MVPA and BMI was only observed for this subgroup.

Table 3. Subgroup analysis of effects of gene–lifestyle interactions on BMI.

Subgroupsa
Parameters Subgroup 1 (Normal weight, male) Subgroup 2 (Normal weight, female) Subgroup 3 (Obese, male) Subgroup 4 (Obese, female)
Number of participants n = 3,952 n = 5,221 n = 1,683 n = 1,262
Random effects Variance Standard deviation Variance Standard deviation Variance Standard deviation Variance Standard deviation
Recruited sites (intercept) 0.03 0.18 0.10 0.32 0.03 0.17 0.04 0.21
Residual 2.50 1.58 2.65 1.63 2.75 1.66 2.74 1.66
Fixed effects Estimate 95% CI p-value Estimate 95% CI p-value Estimate 95% CI p-value Estimate 95% CI p-value
Intercept 22.35 22.22, 22.47 < 0.001 21.56 21.38, 21.75 < 0.001 26.83 26.67, 26.98 < 0.001 26.90 26.71, 27.09 < 0.001
GRS (high GRS subgroup) 0.21 0.11, 0.31 < 0.001 0.21 0.12, 0.30 < 0.001 0.32 0.16, 0.48 < 0.001 0.22 0.03, 0.40 0.022
Age (years) 0.10 0.05, 0.15 < 0.001 0.27 0.22, 0.32 < 0.001 0.04 -0.09, 0.16 0.652 -
Protein - - - 0.14 0.02, 0.25 0.018
Saturated fatty acids 0.07 0.01, 0.12 0.01 - - -
n-3 polyunsaturated fatty acids - 0.03 -0.06, 0.11 0.524 - -
n-6 polyunsaturated fatty acids - 0.12 0.05, 0.19 < 0.001 - -
Carbohydrate - 0.07 0.02, 0.12 0.003 - 0.14 0.04, 0.24 0.008
Soluble dietary fiber -0.10 -0.16, -0.03 -0.16 - -0.13 -0.22, -0.04 0.005 -0.14 -0.24, -0.03 0.011
Insoluble dietary fiber - -0.12 -0.17, -0.07 < 0.001 - -
Retinol 0.06 0.002, 0.11 0.002 - - -
Vitamin E 0.10 0.04, 0.16 0.04 - - -
Vitamin B1 - 0.04 -0.03, 0.11 0.308 - -
Calcium - - -0.12 -0.21, -0.03 0.012 -
Moderate-to-vigorous physical activity -0.07 -0.12, -0.01 -0.12 - - -
Sitting time - - - -0.03 -0.18, 0.13 0.757
GRS * age - - -0.26 -0.43, -0.10 0.001 -
GRS * n-3 polyunsaturated fatty acids - -0.12 -0.22, -0.03 0.011 - -
GRS * vitamin B1 - 0.10 0.01, 0.20 0.035 - -
GRS * sitting time - - - 0.20 0.01, 0.39 0.036

Continuous variables other than BMI and GRS were standardized based on z-score. Variables selected by the backward reduction from the following fixed effects are shown: GRS (lower and upper halves coded as 0 and 1), age, BMI measurement method (calculated from examined or self-reported height and weight coded as 0 and 1), energy, protein, saturated fatty acids, monounsaturated fatty acids, n-3 polyunsaturated fatty acids, n-6 polyunsaturated fatty acids, carbohydrate, soluble dietary fiber, insoluble dietary fiber, retinol, vitamin D, vitamin E, vitamin B1, vitamin B2, folate, vitamin C, iron, and calcium, alcohol intake, moderate-to-vigorous physical activity, sitting time, interaction terms between GRS and age, and each lifestyle factor. Hyphens indicate variables that were eliminated in the variable selection procedure. GRS, genetic risk score; CI, confidence interval.

aSubgroup 1; male, BMI >18.5 kg/m2”nd <‘5 kg/m2: Subgroup 2; female BMI >18.5 kg/m2 and <25 kg/m2: Subgroup 3; male BMI ≥25 kg/m2: Subgroup 4; female BMI ≥25 kg/m2.

Fig 2. Subgroup analysis of the interaction between GRS and various lifestyle factors.

Fig 2

Red and blue lines indicate regression lines for each subgroup, i.e., for the lower half (GRS = 0), and upper half (GRS = 1) of GRS. The shading around each regression line shows the 95% confidence interval. One unit of standardized daily intake of n-3 polyunsaturated fatty acids, vitamin B1, age, and sitting time corresponds to 0.4 g, 0.07 mg, 8.9 years of age, and 3.5 h, respectively. Mean values for n-3 polyunsaturated fatty acids, vitamin B1, age, and sitting time are 2.2 g/day, 0.66 mg/day, 54.7 years, and 4.2 h, respectively. Associations between BMI and each factor differed among groups according to the genetic risk. GRS, genetic risk score.

Results of the candidate approach

The LMM for the subgroups in the first to fourth quartiles of the GRS (details in S1 Appendix) is shown in S5 Table. Candidate variables for the interaction analysis were protein, saturated fatty acids, n-3 polyunsaturated fatty acids, n-6 polyunsaturated fatty acids, carbohydrates, retinols, vitamins D, E, B1, and calcium. The β-coefficients and P-values for the interaction term between GRS and each candidate variable are shown in S6 Table and S2 Fig. Calcium intake showed the strongest evidence for the existence of gene–lifestyle interaction (P = 0.0031), followed by saturated fatty acids (P = 0.0078).

Discussion

In this study, the gene–lifestyle interaction between GRS, calculated from 76 SNPs known to be related to BMI based on an ancestry-specific GWAS, and broad lifestyle factors, such as nutrition intake and physical activity, were assessed simultaneously in a single model. The existence of gene–lifestyle interactions in obesity has been controversial. However, our results provide evidence for an effect of a gene–lifestyle interaction on the BMI phenotype.

Interactions between GRS and saturated fatty acids were observed in our analysis of all participants, including lean and obese participants. The mean intake of saturated fatty acids was 11.1, and 11.2 grams per day in high, and low GRS groups respectively, whereas for participants reporting low saturated fatty acid intake, BMI was higher in the high GRS group. This may be interpreted as reverse causation based on research in nutrition science, rather than an effect of saturated fatty acid intake on BMI. In other words, individuals who possess a higher BMI tend to abstain from saturated fatty acid intake (e.g., milk, beef, and pork [S1 Fig]). Results contradicting the results from prior studies [33, 34] might be due to the differences in ethnicity. Another reason might be the nature of the partial regression coefficient obtained from the analysis, while other predictors were held constant. Although this is the same for other predictor variables, individuals who possess a high GRS and higher BMI could focus on factors associated with BMI described in Table 2 other than saturated fatty acids, such as decreasing energy intake (protein, fats, and carbohydrate), increasing soluble dietary fiber intake and decreasing sitting time, because these are consistent with the known evidence [35, 36]. Incorporating a dietary pattern, which is also indicated in the prior literature, in the future study is an idea to solve challenges in interpreting the partial regression coefficient.

This study had a few key strengths. For example, whereas most studies of gene–lifestyle interactions have focused on specific genes [4, 5], which may be sufficient for single-gene disorders, we used a GRS involving multiple loci, which is more appropriate for multifactorial diseases like obesity. Accounting for many SNPs can lead to a more precise evaluation of the disease risk [23, 37]. In addition, we calculated GRS based on a GWAS of a population with the same ancestry as the study population [23]. GWAS results often differ depending on populations [38]; however, these differences have not been considered in some previous studies of gene–lifestyle interactions [4]. We observed a gene–lifestyle interaction in subgroup 4 (females with obesity), while the sample size in this subgroup was the smallest among all four subgroups. This suggests that the use of SNPs and beta coefficients reported in the GWAS on the Japanese population contributed to observing the gene–environment interaction in the smallest subgroup. Moreover, the results of the subgroup analyses are important for indicating an interaction effect for the groups that are classified with a combination of population group (sex) and phenotypic information (BMI), which includes basic key tiers considered in personalized therapy [12].

The J-MICC study included multiple lifestyle factors, enabling us to evaluate multiple parameters simultaneously. In particular, we assessed nutritional intake and physical activity in a single model. In addition, both MVPA and sitting time data were available as indicators of physical activity. Although we obtained similar results from the candidate approach, the interaction involving calcium was confounded with saturated fatty acid intake since these are both highly correlated with milk consumption (S1 Fig). Most previous studies have focused on either nutrition or physical activity, making those studies unable to assess marginal effects that consider confounding effects on each other [4]. Our comprehensive analysis of both nutritional factors and physical activity resulted in the detection of gene–lifestyle interactions, despite somewhat contradictory evidence for such an interaction to date.

A subgroup analysis suggested that stratification according to age, sex, and BMI is necessary for assessing the gene–lifestyle interaction precisely. We constructed four subgroups according to BMI and sex to evaluate interaction effects. Our use of ancestry-specific GRS might explain our ability to detect an interaction in subgroup 4, despite the small sample size, although the interaction effect may have been particularly strong. In subgroup 2, the negative association between n-3 polyunsaturated fatty acid intake and GRS was only observed for the high GRS subgroup, similar to the main analysis. Hence, we speculate that a reverse causation exists, i.e., that females with a normal weight that tend to have low weight (low GRS) can intake more saturated fatty acids than those with a high weight (high GRS) because the former group does not have to restrict diet. Consequently, the negative association was observed only in females with normal weight. In this context, differences in the effects of gene–lifestyle interactions depending on factors such as sex and BMI may explain the lack of evidence for interaction effects in the literature.

Our focus on sex and BMI as stratifying factors is based on the previously established difference in BMI between males and females as well as biological characteristics, such as endocrinological (hormonal) characteristics [39]. Furthermore, BMI was selected as a stratifying factor because self-reporting bias is known to be more prevalent in obese subjects [4043], and the effect of the genetic variants (GRS) is greater for subjects with relatively high BMI [4, 9]. This does not contradict our results indicating that gene–lifestyle interactions are found in both obese subgroups, despite the smaller sample size.

Age was considered as a covariate in the LMM and not a stratifying factor, in part owing to the limited number of participants. Performing the interaction analysis for the subgroups allowed us to identify an interaction between GRS and age in subgroup 3 (males with obesity). Interaction between GRS and age may be explained by the difference in BMI affecting loci and its effect sizes caused by the difference in obesogenic factors with respect to age [4446]. This raises the hypothesis that genetic variation causes differences in the behavioral response to the obesogenic environment, leading to a difference in BMI [44]. Indeed, the association between GRS and BMI was stronger for relatively younger participants (40–50 years old) within subgroup 3 (Fig 2). Accordingly, studies of GRS or gene–environment interactions should consider the effects of age, sex, and BMI, which may also apply to GWAS of obesity. The female subgroup or the young male subgroup are candidate populations for further analyses of interactions based on our results.

Our study had several limitations. First, as pointed out in a previous methodological review, BMI, an outcome in both the GWAS and our study, does not precisely reflect body composition, such as body fat or lean body mass [5]. Thus, variance in lean body mass, even for the same BMI, may limit our ability to detect associations with obesity. Second, causal inferences were difficult owing to our cross-sectional study design, and the outcome was not the degree of change in BMI. As mentioned above, saturated fatty acids were considered to be observing the reverse causation. Another example was seen for the association between BMI and physical activity among the subgroups; participants in subgroups 1 and 4 were slightly older (S3 Table), and this might have resulted in observing the association between physical activity and BMI only in these subgroups, i.e., individuals who have difficulty in locomotion tend to have a low BMI owing to loss of lean body mass in subgroup 4. In addition, because our study focused on the general population, mainly recruited in conjunction with specific health checkups [47], participants with a higher BMI had a higher chance of requiring past health guidance (specific health guidance) [47] regarding diet or physical activity. Third, the results are biased due to the self-reporting nature of the study, as nutritional intake, physical activity, and BMI data for about 20% of the participants were self-reported.

Conclusions

We detected interactions between GRS and nutritional intake and physical activity. Although further study is required to apply these gene–lifestyle interactions in practice, these results provide a basis for the development of optimal prevention or treatment interventions for obesity according to genetic factors, which is expected to substantially improve effectiveness. Further studies of gene–lifestyle interactions stratified by age, sex, and BMI using the degree of change in BMI as an outcome are needed.

Supporting information

S1 Fig. Correlation plot between nutrients and foods.

Each number in the matrix indicates correlation coefficients for each pair of nutrients (rows) and foods (columns). *Natto is fermented soybeans, tarako is a salted sack made from pollock or cod roe, chikuwa is a processed fish paste, and ganmodoki is deep-fried tofu fritters. SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; n-3 PUFA, n-3 polyunsaturated fatty acids; n-6 PUFA, n-6 polyunsaturated fatty acids; SDF, soluble dietary fiber; IDF, insoluble dietary fiber.

(TIF)

S2 Fig. P-values of the interaction terms observed in the candidate approach.

Each dot indicates the p-value for the interaction terms between GRS and each candidate variable in the linear-mixed model. The dependent variable of the model was BMI, with a recruited site-specific random intercept, and the fixed effect was age, sex, GRS, the interaction term between age and sex, and the interaction term between GRS and candidate variable. GRS, genetic risk score.

(TIF)

S1 Table. BMI-associated loci in the Japanese population.

(PDF)

S2 Table. Number of participants recruited at each site.

(PDF)

S3 Table. Characteristics of the subgroups of participants according to BMI and sex.

(PDF)

S4 Table. Sensitivity analysis excluding participants recruited at Cancer Center.

(PDF)

S5 Table. Subgroup analysis by GRS for the candidate approach.

(PDF)

S6 Table. Beta coefficients and P-values for the interaction analysis in the candidate approach.

(PDF)

S1 Appendix. Supplementary methods.

(PDF)

Acknowledgments

We thank Drs Nobuyuki Hamajima and Hideo Tanaka for their work in initiating and organizing the J-MICC Study as former principal investigators. We thank Editage (www.editage.com) for English language editing.

Data Availability

Data cannot be shared publicly because of ethical reasons. Data described in the manuscript will be made available upon application and approval from the J-MICC study group (http://cohort.umin.jp/english/form/index.html) for researchers who meet the criteria for access to confidential data.

Funding Statement

This study was supported by Grants-in-Aid for Scientific Research for Priority Areas of Cancer (No. 17015018) and Innovative Areas (No. 221S0001) and by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant (No. 16H06277 [CoBiA]) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. This work was also supported in part by funding for the BioBank Japan Project from the Japan Agency for Medical Research and Development since April 2015, and the Ministry of Education, Culture, Sports, Science and Technology from April 2003 to March 2015. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017;377:13–27. doi: 10.1056/NEJMoa1614362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Booth KM, Pinkston MM, Poston WS. Obesity and the built environment. J Am Diet Assoc 2005;105(Suppl 1):S110–S117. doi: 10.1016/j.jada.2005.02.045 [DOI] [PubMed] [Google Scholar]
  • 3.Egger G, Swinburn B. An “ecological” approach to the obesity pandemic. BMJ 1997;315:477–480. doi: 10.1136/bmj.315.7106.477 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Goodarzi MO. Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications. Lancet Diabetes Endocrinol 2018;6:223–236. doi: 10.1016/S2213-8587(17)30200-0 [DOI] [PubMed] [Google Scholar]
  • 5.Reddon H, Guéant JL, Meyre D. The importance of gene-environment interactions in human obesity. Clin Sci (Lond) 2016;130:1571–1597. doi: 10.1042/CS20160221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med 2020;12:44. doi: 10.1186/s13073-020-00742-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Qi Q, Chu AY, Kang JH, Jensen MK, Curhan GC, Pasquale LR, et al. Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med 2012;367:1387–1396. doi: 10.1056/NEJMoa1203039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Nakamura S, Narimatsu H, Sato H, Sho R, Otani K, Kawasaki R, et al. Gene-environment interactions in obesity: implication for future applications in preventive medicine. J Hum Genet 2016;61:317–322. doi: 10.1038/jhg.2015.148 [DOI] [PubMed] [Google Scholar]
  • 9.Tyrrell J, Wood AR, Ames RM, Yaghootkar H, Beaumont RN, Jones SE, et al. Gene-obesogenic environment interactions in the UK Biobank study. Int J Epidemiol 2017;46:559–575. doi: 10.1093/ije/dyw337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wang T, Huang T, Kang JH, Zheng Y, Jensen MK, Wiggs JL, et al. Habitual coffee consumption and genetic predisposition to obesity: gene-diet interaction analyses in three US prospective studies. BMC Med 2017;15:97. doi: 10.1186/s12916-017-0862-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Heianza Y, Qi L. Gene-diet interaction and precision nutrition in obesity. Int J Mol Sci 2017;18:E787. doi: 10.3390/ijms18040787 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ferguson LR, De Caterina R, Görman U, Allayee H, Kohlmeier M, Prasad C, et al. Guide and position of the International Society of nutrigenetics/nutrigenomics on personalised nutrition: Part 1 –Fields of precision nutrition. J Nutrigenet Nutrigenomics 2016;9:12–27. doi: 10.1159/000445350 [DOI] [PubMed] [Google Scholar]
  • 13.Hamajima N, J-MICC Study Group. The Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study) to detect gene-environment interactions for cancer. Asian Pac J Cancer Prev 2007;8:317–323. [PubMed] [Google Scholar]
  • 14.Takeuchi K, Naito M, Kawai S, Tsukamoto M, Kadomatsu Y, Kubo Y, et al. Study profile of the Japan Multi-institutional Collaborative Cohort (J-MICC) Study. J Epidemiol 2021;31:660–668. doi: 10.2188/jea.JE20200147 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 2015;4:7. doi: 10.1186/s13742-015-0047-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559–575. doi: 10.1086/519795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM et al. A global reference for human genetic variation. Nature 2015;526:68–74. doi: 10.1038/nature15393 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904–909. doi: 10.1038/ng1847 [DOI] [PubMed] [Google Scholar]
  • 19.Yamaguchi-Kabata Y, Nakazono K, Takahashi A, Saito S, Hosono N, Kubo M, et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet 2008;83:445–456. doi: 10.1016/j.ajhg.2008.08.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hishida A, Nakatochi M, Akiyama M, Kamatani Y, Nishiyama T, Ito H, et al. Genome-wide association study of renal function traits: results from the Japan multi-institutional collaborative cohort study. Am J Nephrol 2018;47:304–316. doi: 10.1159/000488946 [DOI] [PubMed] [Google Scholar]
  • 21.Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods 2013;10:5–6. doi: 10.1038/nmeth.2307 [DOI] [PubMed] [Google Scholar]
  • 22.Das S, Forer L, Schönherr S, Sidore C, Locke AE, Kwong A, et al. Next-generation genotype imputation service and methods. Nat Genet 2016;48:1284–1287. doi: 10.1038/ng.3656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Akiyama M, Okada Y, Kanai M, Takahashi A, Momozawa Y, Ikeda M, et al. Genome-wide association study identifies 112 new loci for body mass index in the Japanese population. Nat Genet 2017;49:1458–1467. doi: 10.1038/ng.3951 [DOI] [PubMed] [Google Scholar]
  • 24.Tokudome S, Goto C, Imaeda N, Tokudome Y, Ikeda M, Maki S. Development of a data-based short food frequency questionnaire for assessing nutrient intake by middle-aged Japanese. Asian Pac J Cancer Prev 2004;5:40–43. [PubMed] [Google Scholar]
  • 25.Tokudome Y, Goto C, Imaeda N, Hasegawa T, Kato R, Hirose K, et al. Relative validity of a short food frequency questionnaire for assessing nutrient intake versus three-day weighed diet records in middle-aged Japanese. J Epidemiol 2005;15:135–145. doi: 10.2188/jea.15.135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Imaeda N, Goto C, Tokudome Y, Hirose K, Tajima K, Tokudome S. Reproducibility of a short food frequency questionnaire for Japanese general population. J Epidemiol 2007;17:100–107. doi: 10.2188/jea.17.100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Uemura H, Katsuura-Kamano S, Iwasaki Y, Arisawa K, Hishida A, Okada R, et al. Independent relationships of daily life activity and leisure-time exercise with metabolic syndrome and its traits in the general Japanese population. Endocrine 2019;64:552–563. doi: 10.1007/s12020-019-01926-9 [DOI] [PubMed] [Google Scholar]
  • 28.Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381–1395. doi: 10.1249/01.MSS.0000078924.61453.FB [DOI] [PubMed] [Google Scholar]
  • 29.R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/. 2020.
  • 30.Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw 2015;67:1–48. [Google Scholar]
  • 31.Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest package: tests in linear mixed effects models. J Stat Softw 2017;82:1–26. [Google Scholar]
  • 32.Weisberg J FaS. An R Companion to Applied Regression. 3rd ed. SAGE, Thousand Oaks, CA. 2019. [Google Scholar]
  • 33.Corella D, Tai ES, Sorlí JV, Chew SK, Coltell O, Sotos-Prieto M, et al. Association between the APOA2 promoter polymorphism and body weight in Mediterranean and Asian populations: replication of a gene-saturated fat interaction. Int J Obes (Lond) 2011;35:666–675. doi: 10.1038/ijo.2010.187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Casas-Agustench P, Arnett DK, Smith CE, Lai CQ, Parnell LD, Borecki IB, et al. Saturated fat intake modulates the association between an obesity genetic risk score and body mass index in two US populations. J Acad Nutr Diet 2014;114:1954–1966. doi: 10.1016/j.jand.2014.03.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract 2016;22(Suppl 3):1–203. [DOI] [PubMed] [Google Scholar]
  • 36.Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. J Am Coll Cardiol 2014;63:2985–3023. doi: 10.1016/j.jacc.2013.11.004 [DOI] [PubMed] [Google Scholar]
  • 37.Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 2018;50:1219–1224. doi: 10.1038/s41588-018-0183-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet 2019;51:584–591. doi: 10.1038/s41588-019-0379-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol 2015;402:113–119. doi: 10.1016/j.mce.2014.11.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Wehling H, Lusher J. People with a body mass index ⩾30 under-report their dietary intake: A systematic review. J Health Psychol 2019;24:2042–2059. [DOI] [PubMed] [Google Scholar]
  • 41.Murakami K, Sasaki S, Okubo H, Freshmen in Dietetic Courses Study II Group. Characteristics of under- and over-reporters of energy intake among young Japanese women. J Nutr Sci Vitaminol (Tokyo) 2012;58:253–262. [PubMed] [Google Scholar]
  • 42.Murakami K, Livingstone MB. Prevalence and characteristics of misreporting of energy intake in US adults: NHANES 2003–2012. Br J Nutr 2015;114:1294–1303. doi: 10.1017/S0007114515002706 [DOI] [PubMed] [Google Scholar]
  • 43.Murakami K, Livingstone MBE, Okubo H, Sasaki S. Prevalence and characteristics of misreporting of energy intake in Japanese adults: the 2012 National Health and Nutrition Survey. Asia Pac J Clin Nutr 2018;27:441–450. doi: 10.6133/apjcn.042017.11 [DOI] [PubMed] [Google Scholar]
  • 44.Walter S, Mejía-Guevara I, Estrada K, Liu SY, Glymour MM. Association of a genetic risk score with body mass index across different birth cohorts. JAMA 2016;316:63–69. doi: 10.1001/jama.2016.8729 [DOI] [PubMed] [Google Scholar]
  • 45.Tanisawa K, Ito T, Sun X, Ise R, Oshima S, Cao ZB, et al. Strong influence of dietary intake and physical activity on body fatness in elderly Japanese men: age-associated loss of polygenic resistance against obesity. Genes Nutr 2014;9:416. doi: 10.1007/s12263-014-0416-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Winkler TW, Justice AE, Graff M, Barata L, Feitosa MF, Chu S, et al. The influence of age and sex on genetic associations with adult body size and shape: A large-scale genome-wide interaction study. PLOS Genet 2015;11:e1005378. doi: 10.1371/journal.pgen.1005378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.OECD. OECD reviews of public health: Japan: A healthier tomorrow. OECD Reviews of Public. Health, OECD Publishing, Paris. 2019; doi: 10.1787/9789264311602-en [DOI]

Decision Letter 0

Karen M Davison

4 Jul 2022

PONE-D-21-21985Effects of gene–lifestyle interactions on obesity based on a multi-locus risk score: cross-sectional analysisPLOS ONE

Dear Dr. Nakamura,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Karen M Davison, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating in your Funding Statement: "This study was supported by Grants-in-Aid for Scientific Research for Priority Areas of Cancer (No. 17015018) and Innovative Areas (No. 221S0001) and by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant (No. 16H06277 [CoBiA]) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. This work was also supported in part by funding for the BioBank Japan Project from the Japan Agency for Medical Research and Development since April 2015, and the Ministry of Education, Culture, Sports, Science and Technology from April 2003 to March 2015."

Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. 

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

4. Thank you for stating the following financial disclosure: "This study was supported by Grants-in-Aid for Scientific Research for Priority Areas of Cancer (No. 17015018) and Innovative Areas (No. 221S0001) and by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant (No. 16H06277 [CoBiA]) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. This work was also supported in part by funding for the BioBank Japan Project from the Japan Agency for Medical Research and Development since April 2015, and the Ministry of Education, Culture, Sports, Science and Technology from April 2003 to March 2015."

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript by Nakamura et al reports on a cross-sectional study assessing the gene environment interaction between a number of dietary and physical activity. This comprehensive reasonably large study includes many useful predictors to assess the impact on BMI.

This reviewer has the following suggestions to improve the manuscript.

Methods:

Study population: It will be helpful if the authors mention that the population was from Japan.

“local population” is obvious for the authors, but not necessarily for a reader outside of Japan. One needs to infer this. They could use: “participants were residents of Japan who participated…..”

How many patients were assessed from the first visit to the cancer hospital. Individuals coming in for cancer visits may or may not be normal. Might these provide confounding for the results. Will it be useful to undertake analysis without these patients to see if there is an impact of these individuals on the results. If there is no impact of these, the authors may include all cases, but it will be useful to report this, as these patients are likely to be different. It is also possible that these patients are already excluded in the outlier removal undertaken in the methods.

Lines 160-164: The physical activity classification using METs is not clear from the explanation provided here. This reviewer tried to read reference # 25, a prior publication of the same cohort, where the levels seem to be different from 5 described here and not straight forward.

Statistical analysis:

Clear and detailed enough to understand the methods. This reviewer is curious to know whether subgroup analysis was performed by sex only. This is frequent in a cohort of this nature, and it will be useful to report even if the results were not informative in such an analysis.

Lines 150-151: Is this the GRS range identified in the cohort? What does the theoretical range mean? If this is indeed the range for the cohort, this should belong to the results section.

Lines 195-196: It is not clear what do the authors mean by candidate approach? Does it mean “univariate” v/s multivariable for the final model? The S4 table suggests use of a multivariable model with selection of predictors. It appears to be subgroup analysis by GRS quartiles. What is the goal of this analysis?

Results:

In general, if the 95% CI is provided in addition to the coefficient, standard error is not required in the table. 95% CI is more informative, and it is suggested that the authors stick with this, rather than SD.

Lines 208-209: This result can be better reported as: “The increase in BMI for every unit increase in the GRS was 2.45 (95% CI xxx-xxx, p <.001).” When one is using weighted GRS, is the unit of increase per risk allele, or per unit increase in GRS?

Table 1: While the table is provided as upper and lower half of GRS, the way to make these subgroups is not clear. Are the 2 subgroups divided at 0? This would be clear if they provided the results of the GRS obtained for the cohort, and clarified that it was divided into 2 groups

It will be useful to provide an overview summary of the results in the tables in 1 or 2 sentences, e.g. there was no difference in the age, sex distribution or the captured environmental variables when compared by the two subgroups of the GRS (Table 1).

Lines 216- onwards for Gene-lifestyle interaction analysis: This section should also include some better language description of the results connecting them with the methods.

e.g. Using the stepwise regression with backward selection, xxx predictors of relevance were selected for the final model.

Line 266: From Table 2, the p-value for the interaction, GRS* saturated fats is 0.016, different from the one in text. Can the authors please verify.

Do the authors have any plausible explanation for the interaction between GRS and age?

In the high GRS group, every year increase in age decreases the BMI by 0.11 (decrease in 1.1/decade)? While this manuscript is focused on the gene-environment effect, this interaction cannot be completely ignored, and needs at least a comment.

Discussion:

This is a cross-sectional study. Hence, the results of the LMM models suggest association. Association is not causation, and it is not appropriate to use the results of the regression models to suggest this.

It is understandable that the results are contrary to the hypothesis for saturated fatty acids. As the authors suggest, it is possible that the negative association may reflect that the recruited patients may be already involved in health counseling. However, it is not appropriate to suggest that this association means that individuals with higher GRS would not benefit from counseling for intake of saturated fatty acids. The analysis from this cross-sectional study will not be able to address such a question. They need to incorporate the results in the context of prior literature.

The authors have selectively addressed the results of the saturated fats interaction with little attention to other results. It is not clear why this was done. There are other lifestyle factors that were statistically significant in the results that need further attention, literature review and better context in discussion.

For wider applicability of results, it may be useful to compare the results of this study with similar studies in different race/ethnic groups.

Reviewer #2: Good job researching on a complex phenomenon of measuring multi-locus risk score for obesity, considering its relevance in the field of personalized genomics. This topic for the manuscript was very well thought out. It is important to look at the combined effect of gene-lifestyle on BMI and its impact on obesity, as it contributes towards realizing the goals of applying an individual’s personalized gene profile to analyze complex phenotypes. The study provides evidence for an interaction effect between genetic risk score on both nutritional intake and physical activi

It is always a good idea to explore through a national multi-institutional cross-sectional data to test for new hypothesis, as this utilizes data that has had effort and time put in to generate it, thereby decreasing the amount of time and work necessary to generate new data. This is also a great step in moving forward to analyze multiple parameters that may have not been tested earlier. Your overall aim is very interesting as it stems from a logical thought process to generate multi-locus risk score considering the polygenic nature of the genetic interactions. However, the hypothesis if there are any or whether it is a hypothesis free research is not clear in the manuscript.

The manuscript is good for consideration for publication, once the suggestions are incorporated.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: renamed_89f45.docx

PLoS One. 2023 Feb 8;18(2):e0279169. doi: 10.1371/journal.pone.0279169.r002

Author response to Decision Letter 0


31 Jul 2022

Reviewer 1:

Reviewer #1: This manuscript by Nakamura et al reports on a cross-sectional study assessing the gene environment interaction between a number of dietary and physical activity. This comprehensive reasonably large study includes many useful predictors to assess the impact on BMI.

This reviewer has the following suggestions to improve the manuscript.

Methods:

Study population: It will be helpful if the authors mention that the population was from Japan.

“local population” is obvious for the authors, but not necessarily for a reader outside of Japan. One needs to infer this. They could use: “participants were residents of Japan who participated…..”

How many patients were assessed from the first visit to the cancer hospital. Individuals coming in for cancer visits may or may not be normal. Might these provide confounding for the results. Will it be useful to undertake analysis without these patients to see if there is an impact of these individuals on the results. If there is no impact of these, the authors may include all cases, but it will be useful to report this, as these patients are likely to be different. It is also possible that these patients are already excluded in the outlier removal undertaken in the methods.

Lines 160-164: The physical activity classification using METs is not clear from the explanation provided here. This reviewer tried to read reference # 25, a prior publication of the same cohort, where the levels seem to be different from 5 described here and not straight forward.

Statistical analysis:

Clear and detailed enough to understand the methods. This reviewer is curious to know whether subgroup analysis was performed by sex only. This is frequent in a cohort of this nature, and it will be useful to report even if the results were not informative in such an analysis.

Lines 150-151: Is this the GRS range identified in the cohort? What does the theoretical range mean? If this is indeed the range for the cohort, this should belong to the results section.

Lines 195-196: It is not clear what do the authors mean by candidate approach? Does it mean “univariate” v/s multivariable for the final model? The S4 table suggests use of a multivariable model with selection of predictors. It appears to be subgroup analysis by GRS quartiles. What is the goal of this analysis?

Results:

In general, if the 95% CI is provided in addition to the coefficient, standard error is not required in the table. 95% CI is more informative, and it is suggested that the authors stick with this, rather than SD.

Lines 208-209: This result can be better reported as: “The increase in BMI for every unit increase in the GRS was 2.45 (95% CI xxx-xxx, p <.001).” When one is using weighted GRS, is the unit of increase per risk allele, or per unit increase in GRS?

Table 1: While the table is provided as upper and lower half of GRS, the way to make these subgroups is not clear. Are the 2 subgroups divided at 0? This would be clear if they provided the results of the GRS obtained for the cohort, and clarified that it was divided into 2 groups

It will be useful to provide an overview summary of the results in the tables in 1 or 2 sentences, e.g. there was no difference in the age, sex distribution or the captured environmental variables when compared by the two subgroups of the GRS (Table 1).

Lines 216- onwards for Gene-lifestyle interaction analysis: This section should also include some better language description of the results connecting them with the methods.

e.g. Using the stepwise regression with backward selection, xxx predictors of relevance were selected for the final model.

Line 266: From Table 2, the p-value for the interaction, GRS* saturated fats is 0.016, different from the one in text. Can the authors please verify.

Do the authors have any plausible explanation for the interaction between GRS and age?

In the high GRS group, every year increase in age decreases the BMI by 0.11 (decrease in 1.1/decade)? While this manuscript is focused on the gene-environment effect, this interaction cannot be completely ignored, and needs at least a comment.

Discussion:

This is a cross-sectional study. Hence, the results of the LMM models suggest association. Association is not causation, and it is not appropriate to use the results of the regression models to suggest this.

It is understandable that the results are contrary to the hypothesis for saturated fatty acids. As the authors suggest, it is possible that the negative association may reflect that the recruited patients may be already involved in health counseling. However, it is not appropriate to suggest that this association means that individuals with higher GRS would not benefit from counseling for intake of saturated fatty acids. The analysis from this cross-sectional study will not be able to address such a question. They need to incorporate the results in the context of prior literature.

The authors have selectively addressed the results of the saturated fats interaction with little attention to other results. It is not clear why this was done. There are other lifestyle factors that were statistically significant in the results that need further attention, literature review and better context in discussion.

For wider applicability of results, it may be useful to compare the results of this study with similar studies in different race/ethnic groups.

Manuscript: Effects of gene–lifestyle interactions on obesity based on a multi-locus risk score: cross-sectional analysis

General and Scientific comments:

Good job researching on a complex phenomenon of measuring multi-locus risk score for obesity, considering its relevance in the field of personalized genomics. This topic for the manuscript was very well thought out. It is important to look at the combined effect of gene-lifestyle on BMI and its impact on obesity, as it contributes towards realizing the goals of applying an individual’s personalized gene profile to analyze complex phenotypes. The study provides evidence for an interaction effect between genetic risk score on both nutritional intake and physical activi

It is always a good idea to explore through a national multi-institutional cross-sectional data to test for new hypothesis, as this utilizes data that has had effort and time put in to generate it, thereby decreasing the amount of time and work necessary to generate new data. This is also a great step in moving forward to analyze multiple parameters that may have not been tested earlier. Your overall aim is very interesting as it stems from a logical thought process to generate multi-locus risk score considering the polygenic nature of the genetic interactions. However, the hypothesis if there are any or whether it is a hypothesis free research is not clear in the manuscript.

The manuscript is good for consideration for publication, once the suggestions are incorporated.

My overall suggestions would be:

- To be more descriptive in the introduction and discussion e.g., mentioning about nutrigenomics and its’ application in personalized genomic based preventative therapy. A couple of sentences can be included in the abstract, introduction and discussion. This will add value to the goal of the study and allow for thinking of the "big picture" that could be stem from this kind of research.

- Describe the data a little more clearly rather than simply stating what your figures/tables represent, it will enable to better understand the thought process. This will enable you to interpret your data better and summarize your findings coherently.

- The tables can be presented more precisely and effectively. There is too much information which is not really adding to the overall analysis, e.g., of better presentation is 95% confidence interval can be written in one column rather than splitting it into lower and upper, as this is quite standard and understandable. Representing Mean and SD can be like Mean ± SD rather than Mean (SD), as in the same table in other rows ‘n/ any other parameters’ is written within brackets. The table design can be more simplistic. This will allow your readers to understand the article better. Otherwise on an overall, good analysis and interpretation of statistical data. It can be hard interpreting retrospective data!

- Overall work on the presentation of the figures as well. It will be good to work on the vocabulary of language. There seems to be repeat of words e.g., words like however occur in too many places, synonyms of which can be used. Checking for typo and punctuation errors wherever necessary e.g.,the citations are after the full stop in most of the places. I understand that the authors have used a translation service. It will be better to ensure that the message conveyed is not lost in translation and it is the correct intended one. I will highlight some of these points in the detailed review below.

Specific stepwise comments on the manuscript:

Abstract

- Line 59- To start with importance of lifestyle and obesity research, like introducing about nutrigenomics and then link it to personalized genomics. This will add value.

Introduction

- Same comment as above, to include points about nutrigenomics and then link it to personalized genomics in the first paragraph.

- Line 95- Using ‘contradictory’ rather than ‘controversial’, which is quite a strong word in the context of this area of research.

- Line 101- GRS is not within brackets! It will be better to shift it to line 100 when genetic risk score is first mentioned.

- Line 105- managing obesity is better than the word healthcare. It is too generic a word to be used in this context.

Materials and methods

- Line 128- DNA was extracted from buffy coat would be more appropriate.

- Line 160- Previously mentioned method, rather than previously method!

- Line 187 to Line 191- This part is unclear. It is mentioned that a sub-group analysis was performed on sex. However, on line 190 and 191, it mentioned as sex was excluded from sub-group analysis. It would be good to verify on this.

Results

- Line 207- Correlation is represented as r, using the symbol for rho would be appropriate.

- Table 1- As mentioned earlier, better to write Mean and SD can be like Mean ± SD rather than Mean (SD). In each row the value within the bracket indicates a different parameter. Could probably find better ways to simplify it! Just a suggestion!

- Describe more about the details of what the table 2 and 3 is conveying in the appropriate place.

- Table 3- In the ‘age’ row, the values are in fraction. Not sure why the age is being represented in fraction!

Discussion

- Line 299- Change from ‘depending among populations’ to “depending on populations”

- Line 302 & 303- Not clear what is being indicated here, is it the suggestion for the entire findings or just the previous sub-group 4 findings. Also, changing ‘GWAS of the Japanese population’ to “GWAS on the Japanese population” is suggested.

- Line 310 & 312- Not clear interpretation, adding more details will add value. Mentioning contradictory is as controversial gives a very different tone.

- Line 329-Better to replace ‘a relative’ with “relatively”

- Line 339- This sentence “younger participants (40–50 years old) in our analysis of subgroup 3” is misleading. Age 40-50 is considered middle age. If it is in comparison, then better to state relatively younger to the other sub-group!

- Line 347-349- The sentence ‘Other than saturated fatty acids, the age of participants differed slightly among subgroups …..’ can be framed better.

- Line 347-349- The sentence ‘mainly recruited at health checkups,…….’ is not clear. Not sure why past health guidance is mentioned.

Attachment

Submitted filename: RESPONSE_TO_REVIEWER_COMMENTS.docx

Decision Letter 1

Tomoyoshi Komiyama

2 Dec 2022

Effects of gene–lifestyle interactions on obesity based on a multi-locus risk score: a cross-sectional analysis

PONE-D-21-21985R1

Dear Dr. Nakamura,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Tomoyoshi Komiyama, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear Authors,

Thank you for submitting your revised manuscript.

Your study analyzed how genetic risk and lifestyle factors (such as nutritional intake and physical activity) are linked to BMI, based on cross-sectional data from the Japan Multi- Institutional Collaborative Cohort Study.

I see you corrected the highlighted sections according to the reviewer’s suggestions.

Also, I found your updated version much clearer than the original.

Therefore, I have no further comments as all of my previous concerns were adequately addressed.

I believe this manuscript will satiate the reader's interest.

Tomoyoshi Komiyama

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Appreciate the authors for incorporating all of the suggested changes. It would be good to review the article for copy-edits and formatting as required by the Journal.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Acceptance letter

Tomoyoshi Komiyama

30 Jan 2023

PONE-D-21-21985R1

Effects of gene–lifestyle interactions on obesity based on a multi-locus risk score: a cross-sectional analysis

Dear Dr. Nakamura:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Tomoyoshi Komiyama

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Correlation plot between nutrients and foods.

    Each number in the matrix indicates correlation coefficients for each pair of nutrients (rows) and foods (columns). *Natto is fermented soybeans, tarako is a salted sack made from pollock or cod roe, chikuwa is a processed fish paste, and ganmodoki is deep-fried tofu fritters. SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; n-3 PUFA, n-3 polyunsaturated fatty acids; n-6 PUFA, n-6 polyunsaturated fatty acids; SDF, soluble dietary fiber; IDF, insoluble dietary fiber.

    (TIF)

    S2 Fig. P-values of the interaction terms observed in the candidate approach.

    Each dot indicates the p-value for the interaction terms between GRS and each candidate variable in the linear-mixed model. The dependent variable of the model was BMI, with a recruited site-specific random intercept, and the fixed effect was age, sex, GRS, the interaction term between age and sex, and the interaction term between GRS and candidate variable. GRS, genetic risk score.

    (TIF)

    S1 Table. BMI-associated loci in the Japanese population.

    (PDF)

    S2 Table. Number of participants recruited at each site.

    (PDF)

    S3 Table. Characteristics of the subgroups of participants according to BMI and sex.

    (PDF)

    S4 Table. Sensitivity analysis excluding participants recruited at Cancer Center.

    (PDF)

    S5 Table. Subgroup analysis by GRS for the candidate approach.

    (PDF)

    S6 Table. Beta coefficients and P-values for the interaction analysis in the candidate approach.

    (PDF)

    S1 Appendix. Supplementary methods.

    (PDF)

    Attachment

    Submitted filename: renamed_89f45.docx

    Attachment

    Submitted filename: RESPONSE_TO_REVIEWER_COMMENTS.docx

    Data Availability Statement

    Data cannot be shared publicly because of ethical reasons. Data described in the manuscript will be made available upon application and approval from the J-MICC study group (http://cohort.umin.jp/english/form/index.html) for researchers who meet the criteria for access to confidential data.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES